12 Cathie Wood Beam Therapeutics Trades
Cathie Wood's position in Beam Therapeutics is currently worth $253 Million. That's 1.64% of their equity portfolio (17th largest holding). The investor owns 11.03% of the outstanding Beam Therapeutics stock. The first Beam Therapeutics trade was made in Q4 2020. Since then Cathie Wood bought shares eight more times and sold shares on three occasions. The investor's estimated purchase price is $676 Million, resulting in a loss of 63%.
Avg closing price
Price range
Increased shares by 4.8% (+401 Thousand shares)
Q3 2023
Avg closing price
$26.81
Price range
$23.01
-
$32.46
Sold 2.2% shares (-191 Thousand shares)
Q2 2023
Avg closing price
$32.45
Price range
$29.32
-
$35.99
Increased shares by 4.4% (+360 Thousand shares)
Q1 2023
Avg closing price
$39.47
Price range
$30.15
-
$48.79
Sold 3.3% shares (-278 Thousand shares)
Q4 2022
Avg closing price
$44.79
Price range
$36.73
-
$51.60
Sold 3.4% shares (-301 Thousand shares)
Q3 2022
Avg closing price
$57.05
Price range
$39.79
-
$70.31
Increased shares by 7.2% (+591 Thousand shares)
Q2 2022
Avg closing price
$39.75
Price range
$29.86
-
$62.36
Increased shares by 2.7% (+217 Thousand shares)
Q1 2022
Avg closing price
$65.59
Price range
$53.73
-
$82.16
Increased shares by 16.7% (+1.14 Million shares)
Q4 2021
Avg closing price
$85.62
Price range
$68.02
-
$99.06
Increased shares by 5.9% (+380 Thousand shares)
Q3 2021
Avg closing price
$100.46
Price range
$84.37
-
$133.60
Increased shares by 35.2% (+1.68 Million shares)
Q2 2021
Avg closing price
$79.68
Price range
$64.12
-
$128.71
Increased shares by 322.3% (+3.65 Million shares)
Q1 2021
Avg closing price
$95.13
Price range
$71.28
-
$120.75
New holding (+1.13 Million shares)
Q4 2020
Avg closing price
$49.18
Price range
$22.24
-
$95.63
